Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof

A technology of polypeptide complexes and prodrugs, which is applied in the direction of antineoplastic drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of no tumor prodrugs, achieve good application and promotion value, and accelerate the effect of enrichment

Inactive Publication Date: 2011-04-20
河南省健康伟业生物医药研究股份有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] So far, no enzyme-activated targeted anti-tumor progenitors have been synthesized using folic acid-directed technology and peptide modification technology, which carry polypeptide structures that are selectively hydrolyzed around tumor stromal cells and have high affinity for folic acid receptors on tumor cells. Related reports on body drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1 Synthesis of folic acid-alanylserylglycylprolyl-doxorubicin (F-ASGP-Dox)

[0039] (1) Synthesize prolyl-resin, measure the loading value of prolyl-resin; synthesize polypeptide-resin;

[0040] A. Synthesis of prolyl-resin

[0041] Weigh 300 mg of 2-chloro-trityl chloride resin (1.0 mmol / g), wash with DCM 3 times, soak in DCM for 5 min, and dry under N2 pressure. Add DCM to 304 mg of Fmoc-proline and 128 mg of DIPEA dropwise until it is completely dissolved, add the mixture to the resin, stir and react for 5 minutes, then add 225 mg of DIPEA, react for 2 to 3 hours, add 300 μl of methanol, and react 10min, the measured loading value is 0.8. Add 1.0 ml of 25% piperidine / DMF to deprotect the Fmoc group. Wash 5 times with DMF, N 2 Press dry.

[0042] B, Synthesis of alanylserylglycylprolyl-resin

[0043] Weigh 147mg of Fmoc-glycine, 285mg of HOBt and 121mg of DIC. After DMF is dissolved, add prolyl-resin. After reacting for 2 to 3 hours, take a small amount ...

Embodiment 2

[0050] Example 2 Synthesis of folic acid-alanylserylglycylprolyl-mephalan (F-ASGP-PAM)

[0051] (1) Synthesize F-ASGP according to the steps (1) and (2) of Example 1

[0052] (2) Take N folic acid-alanyl seryl glycyl proline and dissolve it in N,N-dimethylformamide, add the anti-tumor cytotoxic drug solution dissolved in Et3N DMF after activation, stir and react Afterwards, diethyl ether was added for extraction, and the diethyl ether extract was subjected to rotary evaporation to obtain the crude product of folic acid-polypeptide-melphalan.

[0053] Weigh 5 mg of F-ASGP and dissolve in 1 ml of N,N-dimethylformamide (DMF), add 2 μl of ethyl chloroformate, and stir at room temperature for 2 minutes. Add 2.8 μl triethylamine and stir at room temperature for 1 hour.

[0054] Weigh 2 mg of phenylalanine mustard (PAM) and dissolve it in 0.3 mL of DMF, add 1 μl of triethylamine to it and mix well. Add the dissolved melphalan into the activated F-ASGP solution, and stir at room te...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a target antitumor prodrug which is mediated by a folic acid-polypeptide composite; the constructive general formula of the invention is X-ASGP-Cyt'. The invention also discloses a typical prodrug of folic acid-polypeptide-adriamycin. Meanwhile, the invention discloses the preparation method of the prodrug. Specificity substrate alanyl-seryl-glycyl-proline (ASGP) polypeptide is utilized as connexin, free carboxyl is used for modifying the free amino-group of adriamycin and other antitumor drugs, and the free amino-group is connected to the carboxyl of folic acid so as to synthesize the enzyme activation type target antitumor prodrug carrying polypeptide, which can be selectively hydrolyzed around tumorous interstitial cells, and folic acid, which has high affinity with the folate receptors on tumorous interstitial cells, thus accelerating the active enrichment of the antitumor drug toward specific tumor tissues and achieving the aim of hydrolyzing and releasingthe target cytotoxia drug surrounding tumor tissues.

Description

technical field [0001] The invention belongs to the technical field of biology and medicine, and specifically relates to a targeted anti-tumor prodrug mediated by a folic acid-polypeptide complex and a preparation method thereof. Background technique [0002] Targeted anti-tumor molecular drugs are based on the differences in molecular biology between tumor cells and normal cells, and selectively act on genes, enzymes, signal transduction molecules, etc. of target cells, so as to achieve the purpose of treatment. Examples of this include cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR); trastuzumab, a humanized monoclonal antibody targeting the extracellular region of breast cancer cell HER-2; Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor (VEGF) receptors; small molecule EGFR tyrosine kinase inhibitors (gefitinib, erlotinib), etc. Although targeted anti-tumor molecular drug therapy is an ideal treatment...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/48A61K47/42A61K45/00A61K31/704A61P35/00A61K47/22A61K47/65
Inventor 杜军刘鹏卜宪章谢白露
Owner 河南省健康伟业生物医药研究股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap